Quest Diagnostics Incorporated
DGX Healthcare Diagnostics & Research
Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow DGX
Quest Diagnostics Incorporated (DGX) Free cash flow margin
Quest Diagnostics Incorporated's free cash flow margin over the twelve months to 30 June 2026 was 11.7%, down 0.7 percentage points from fiscal 2025 (12.3%). Over the past ten years it has ranged from 7.45% (fiscal 2015) to 17.0% (fiscal 2021); the current reading is higher than 64% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 12.3% | 3.11 |
| FY2024 | 9.21% | (0.13) |
| FY2023 | 9.34% | (3.96) |
| FY2022 | 13.3% | (3.66) |
| FY2021 | 17.0% | 0.14 |
| FY2020 | 16.8% | 5.91 |
| FY2019 | 10.9% | 0.06 |
| FY2018 | 10.9% | (1.62) |
| FY2017 | 12.5% | 1.06 |
| FY2016 | 11.4% | 3.96 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 27.2% |
| MEDP Medpace Holdings, Inc. compare | 25.4% |
| MTD Mettler-Toledo International, Inc. compare | 20.9% |
| ILMN Illumina, Inc. compare | 20.7% |
| RVTY Revvity Inc. compare | 19.6% |
| DGX Quest Diagnostics Incorporated | 11.7% |
| LH Labcorp Holdings Inc. compare | 8.16% |
| WAT Waters Corporation compare | 7.89% |
| GH Guardant Health, Inc. compare | −20.4% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on DGX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement